Head and Neck Carcnimona
1 clinical trials · Condition
◉ Watch Head and Neck Carcnimona
| Record | Firm | Date |
|---|---|---|
| Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS (NCT05879484) | National Cancer Institute (NCI) | 2025-07-09 |
Track Head and Neck Carcnimona automatically
Every clearance here is in the API, with alerts when new ones post.